Weekly News Recap #Phispers
Lilly cuts price of Zepbound; leaked memo on child deaths due to Covid vaccines triggers reaction from former FDA chiefs
In Phispers this week, Eli Lilly reduced prices of its obesity
drug Zepbound sold through LillyDirect, aiming to expand access...
Impressions : 1515
Pfizer’s Covid-19 pill retains 89 percent efficacy, works on Omicron; CSL buys Vifor for US$ 11.7 billion
In
this week’s Phispers, we bring you news on several M&As and tie-ups along with updates on Covid-19 medications an...
Impressions : 1661
Novartis shutters plant of world’s costliest drug; Bharat Biotech’s vaccine rejected by Anvisa due to GMP concerns
This week, Phispers brings you more news on Covid vaccines. In the US, while Pfizer and BioNTech said their vaccine was 100 per...
Impressions : 2732
Gilead signs deals for remdesivir production; Pfizer outsources drug-making to focus on Covid vaccine
This week, Phispers brings you news on how Covid-19 is pushing drugmakers to outsource manufacturing of drugs.
While Gilead s...
Impressions : 146138
FDA highlights data-integrity concerns at Pfizer’s India unit; FDA requests removal of all ranitidine products
This week, N-nitrosodimethylamine (NDMA) is back in news as the FDA requests manufacturers to withdraw ranitidine from the mark...
Impressions : 3649
Astra strikes US$ 6.9 billion oncology deal with Daiichi; Cipla, Jubilant, Indoco’s FDA inspection updates
This week, Phispers brings you news about AstraZeneca’s US$ 6.9 billion deal with Japanese drug major Daiichi Sankyo, whe...
Impressions : 2723
Sanofi and AbbVie CEOs suffer pay cuts, FDA Warning Letters to Pfizer, Jubilant’s Indian operations
This week, Phispers brings you news about two antidepressants — J&J’s esketamine and Allergan’s rapastine...
Impressions : 3607
Teva to exit 80 percent generics portfolio in US; Takeda clinches Shire for US$ 62 billion
This week in Phispers, we report on the biggest deal of 2018 yet — Takeda’s acquisition of Shire — that would...
Impressions : 6515
Uber launches Uber Health; More countries join FDA-EU mutual recognition program
This week, Phispers brings you news on Uber Health, a new desktop platform for healthcare providers that allows doctors to prov...
Impressions : 3112
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.